Search

everythinglearnresearchcommunity

for

Search:↓

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Canakinumab's effect on COVID-19 outcomes is unclear.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Higher levels of the DP2 receptor may lead to hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

STS01 1% effectively promotes hair regrowth with minimal side effects.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Apoptosis may play a role in feather and hair development, SF-36 is better for mental health in skin patients, a psoriasis gene is found in Caucasians, eosinophils might not be crucial for some skin allergies, and changes in atopic dermatitis could increase skin sensitivity.

FA2H is essential for normal fur and sebum production in mice.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

COVID-19 increased alopecia areata relapses due to inflammation and stress.